FindTrial
Sign In

A Retrospective Cohort Study Using Formalin-Fixed Paraffin-Embedded Kidney Tissue to Predict Progression and Personalize Treatment in Diabetic Kidney Disease

A Retrospective Cohort Study Using Formalin-Fixed Paraffin-Embedded Kidney Tissue to Predict Progression and Personalize Treatment in Diabetic Kidney Disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0011202
Enrollment
50
Registered
2025-11-24
Start date
2025-11-01
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Korea University Ansan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Among patients who underwent kidney biopsy at Korea University Ansan Hospital from January 1, 2022 to July 31, 2025, patients with residual samples of the pathology of FFPE (Formalin-Fixed Paraffin-Embedded) are secured

Exclusion criteria

Exclusion criteria: ND

Design outcomes

Primary

MeasureTime frame
Obtain formalin-fixed paraffin-embedded (FFPE) organization for kidney residue, and analyze spatial transcriptomics singleomics—

Secondary

MeasureTime frame
Subject information and medical record information—

Countries

Korea, Republic of

Contacts

Public ContactSeungA Park

Korea University Ansan Hospital

redanne@hotmail.com+82-31-8099-3167

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026